Chronic Lymphocytic Leukemia | Exploring Clinical Investigator Perspectives on the Optimal Management of Chronic Lymphocytic Leukemia (for Hematology-Oncology Fellows) - a podcast by Dr Neil Love
from 2021-05-28T18:00
::
::
Featuring perspectives from Dr Jennifer Woyach, including the following topics:
- Front-line therapy for chronic lymphocytic leukemia (CLL) for fellows; use of prognostic biomarkers and cytogenetics in refining risk assessment for patients with newly diagnosed disease — Jennifer Woyach, MD (0:00)
- Bruton tyrosine kinase (BTK) inhibitors for treatment-naïve CLL (8:29)
- Venetoclax/obinutuzumab for treatment-naïve disease; overview of patient selection for chemoimmunotherapy (18:04)
- Relevant biomarkers influencing the selection of therapy for patients with CLL (24:09)
- Impact of biologic and patient-related factors on front-line decision-making (30:24)
- Selection and sequencing of therapies for relapsed/refractory CLL (1:02:53)
- Key considerations and take-home messages (1:13:52)
CME information and select publications
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love